ReviewInternational journal of molecular medicine2018

Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review).

Marina Devetzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.